This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| POZ (magazine) | |
|---|---|
| Title | POZ |
| Frequency | Monthly |
| Category | HIV/AIDS, health, advocacy |
| Firstdate | 1994 |
| Country | United States |
| Language | English |
POZ (magazine) POZ is an American monthly magazine founded in 1994 that covers HIV/AIDS-related news, health, culture, and advocacy. The publication has engaged with figures and institutions across public health, media, and politics, connecting reporting on HIV with coverage of activism, medicine, and popular culture. POZ's pages have featured interviews and analysis involving healthcare leaders, entertainers, and policymakers, situating HIV discourse alongside notable events and organizations.
POZ was launched in 1994 amid the Clinton administration debates on healthcare and the aftermath of the 1990s activism exemplified by Act Up and the legacy of the Ryan White era, emerging alongside publications and organizations such as The Advocate, AIDSinfo, and The New York Times health reporters. Early issues chronicled developments like the approval of protease inhibitors by the Food and Drug Administration and the influence of researchers at institutions such as Harvard University, Johns Hopkins University, and Centers for Disease Control and Prevention clinicians. Throughout the late 1990s and 2000s the magazine covered international policy shifts involving World Health Organization, UNAIDS, and global initiatives including the President's Emergency Plan for AIDS Relief. In the 2010s and 2020s POZ responded to breakthroughs such as pre‑exposure prophylaxis debates involving Gilead Sciences, treatment cascades discussed by World Health Organization, and public health challenges like the opioid crisis linked to HIV outbreaks seen in counties across the United States.
POZ centers reporting on clinical advances, social determinants, and lived experience by integrating contributions that reference trials at places like National Institutes of Health, policy decisions by the U.S. Department of Health and Human Services, and narratives tied to cultural figures from Broadway to Hollywood. Regular features have bridged coverage of antiretroviral research from labs at University of California, San Francisco and Massachusetts General Hospital with profiles of activists associated with groups such as Black AIDS Institute and Terrence Higgins Trust-affiliated counterparts. The magazine blends investigative journalism about pharmaceutical companies including Merck and AbbVie with first-person essays from people connected to organizations like Lambda Legal and Human Rights Campaign. Coverage often situates stories alongside public debates involving the Supreme Court of the United States, federal funding appropriations debated on Capitol Hill, and nonprofit advocacy networks.
POZ has circulated in print and digital formats, sold through retail outlets, subscriptions, and partnerships with healthcare providers and nonprofit organizations including community clinics affiliated with AIDS Healthcare Foundation and university medical centers such as Mayo Clinic. The magazine's digital presence expanded with distribution channels leveraging platforms used by outlets like HIV Plus and mainstream media portals such as The Guardian and The Washington Post syndication networks. Distribution strategies have intersected with conferences and events hosted by groups such as International AIDS Conference and regional forums organized by county health departments and municipal entities like New York City Department of Health and Mental Hygiene.
POZ has played a role in shaping public discourse on HIV policy, amplifying the work of advocates connected to campaigns led by Elizabeth Taylor's legacy foundations, activists in the tradition of Peter Staley, and community organizers linked to networks like ACT UP chapters. Reporting has informed conversations around access to medication from corporations such as Gilead Sciences and patent debates referenced in international negotiations at World Trade Organization forums. The magazine's advocacy journalism has intersected with litigation and rights efforts by organizations like American Civil Liberties Union and policy shifts influenced by testimony before committees on U.S. Congress health subcommittees.
POZ has published work by journalists and advocates who have also been associated with outlets and institutions such as The New Yorker, Rolling Stone, NPR, and academic centers like Columbia University Mailman School of Public Health. Interviews have featured entertainers and public figures from Magic Johnson and activists reminiscent of Larry Kramer to politicians and health officials including speakers tied to U.S. Senate hearings and leaders from Centers for Disease Control and Prevention. Profiles have included conversations with artists and cultural figures who have intersected with HIV discourse across platforms like Sundance Film Festival and Academy Awards–hosted film narratives.
POZ and its contributors have received industry recognition paralleling honors given by journalism and public health institutions such as awards from the National Lesbian and Gay Journalists Association, citations from public health bodies like the American Public Health Association, and acknowledgments in media lists alongside titles like Time (magazine) and Newsweek. Individual pieces and editors have been noted in competitions and fellowships tied to organizations such as Pulitzer Prize–related programs, reporting grants from foundations connected to Robert Wood Johnson Foundation, and honors in LGBT media award circuits.
Category:HIV/AIDS publications Category:American monthly magazines Category:LGBT-related magazines in the United States